Overview
Background
I am interested in ion channels in health and disease. Improved technologies for genetic screening is revealing an expanding catalogue of genetic variants to ion channels that give rise neurological disorders, such as epilespy syndromes, autism spectrum disorder and other neurodevelopmental disorders. My main research focus is on neurotransmitter-activated receptor ion channels that are found at neuronal synapses. These include GABA-A, glycine and glutamate (NMDA) receptors. I also work on other ion channesl such as voltage-gated sodium channels and synaptic receptors expressed in invertebrate nervous systems.
I am an expert at recording single ion channel, synaptic and conventional whole-cell currents for functional and pharmacological analyisis.
I collaborate with biophysicists, molecular biologists, geneticists, electrophysiologists and clinicians that specialise in genetic neurological disorders. I have active projects in collaboration with research groups in Australia, USA and Europe.
Availability
- Dr Angelo Keramidas is:
- Available for supervision
Fields of research
Qualifications
- Bachelor of Science, unknown
- Doctor of Philosophy, unknown
Research impacts
I am collaborating with basic and clinical research groups that bring together a great diversity of research techniques with the common aim of developing personalised medicine for affected individuals with neurological disorders.
Works
Search Professor Angelo Keramidas’s works on UQ eSpace
2004
Journal Article
Ligand-gated ion channels: Mechanisms underlying ion selectivity
Keramidas, Angelo, Moorhouse, Andrew J., Schofield, Peter R. and Barry, Peter H. (2004). Ligand-gated ion channels: Mechanisms underlying ion selectivity. Progress in Biophysics and Molecular Biology, 86 (2), 161-204. doi: 10.1016/j.pbiomolbio.2003.09.002
2003
Journal Article
The contribution of proline 250 (P-2’) to pore diameter and ion selectivity in the human glycine receptor channel
Lee, David J.-S., Keramidas, Angelo, Moorhouse, Andrew J., Schofield, Peter R. and Barry, Peter H. (2003). The contribution of proline 250 (P-2’) to pore diameter and ion selectivity in the human glycine receptor channel. Neuroscience Letters, 351 (3), 196-200. doi: 10.1016/S0304-3940(03)00977-7
2003
Journal Article
The contribution of proline 250 (P-2 ') to pore diameter and ion selectivity in the human glycine receptor channel
Lee, DJS, Keramidas, A, Moorhouse, AJ, Schofield, PR and Barry, PH (2003). The contribution of proline 250 (P-2 ') to pore diameter and ion selectivity in the human glycine receptor channel. Neuroscience Letters, 351 (3), 196-200. doi: 10.1016/S0304-3940(03)00977-7
2003
Conference Publication
Mechanism of ion permeation in the glycine receptor and its cation-selective mutations
O'Mara, Megan, Keramidas, Angelo, Barry, Peter H. and Chung, Shin-Ho (2003). Mechanism of ion permeation in the glycine receptor and its cation-selective mutations. 47th Annual Meeting of the Biophysical Society, San Antonio, Texas, 1-5 March 2003. Bethesda, MD, U.S.A.: Cell Press for the Biophysical Society.
2003
Conference Publication
Mechanism of ion permeation in the glycine receptor and its cation-selective mutations
O'Mara, M., Keramidas, A., Barry, P. H. and Chung, S. H. (2003). Mechanism of ion permeation in the glycine receptor and its cation-selective mutations. 47th Annual Meeting of the Biophysical-Society, San Antonio Texas, 1-5 March 2003. Bethesda, MD United States: Biophysical Society.
2002
Journal Article
Single channel analysis of conductance and rectification in cation-selective, mutant glycine receptor channels
Moorhouse, Andrew J., Keramidas, Angelo, Zaykin, Andrey, Schofield, Peter R. and Barry, Peter H. (2002). Single channel analysis of conductance and rectification in cation-selective, mutant glycine receptor channels. Journal of General Physiology, 119 (5), 411-425. doi: 10.1085/jgp.20028553
2002
Journal Article
Cation-selective mutations in the M2 domain of the inhibitory glycine receptor channel reveal determinants of ion-charge selectivity
Keramidas, Angelo, Moorhouse, Andrew J., Pierce, Kerrie D. and Schofield, Peter R. (2002). Cation-selective mutations in the M2 domain of the inhibitory glycine receptor channel reveal determinants of ion-charge selectivity. Journal of General Physiology, 119 (5), 393-410. doi: 10.1085/jgp.20028552
2000
Journal Article
M2 pore mutations convert the glycine receptor channel from being anion- to cation-selective
Keramidas, A, Moorhouse, AJ, French, CR, Schofield, PR and Barry, PH (2000). M2 pore mutations convert the glycine receptor channel from being anion- to cation-selective. Biophysical Journal, 79 (1), 247-259. doi: 10.1016/S0006-3495(00)76287-4
1999
Journal Article
Measurement of the limiting equivalent conductivities and mobilities of the most prevalent ionic species of EGTA (EGTA2- and EGTA3-) for use in electrophysiological experiments
Keramidas, Angelo , Barry, Peter H., Moorhouse, Andrew and Kuhlmann, Levin (1999). Measurement of the limiting equivalent conductivities and mobilities of the most prevalent ionic species of EGTA (EGTA2- and EGTA3-) for use in electrophysiological experiments. Journal of Neuroscience Methods, 89 (1), 41-47. doi: 10.1016/S0165-0270(99)00036-9
Funding
Current funding
Past funding
Supervision
Availability
- Dr Angelo Keramidas is:
- Available for supervision
Before you email them, read our advice on how to contact a supervisor.
Available projects
-
GABA-A and glycine receptor variants in epilepsy and autism
New gene variants identified by our clinical collaborators to receptors that mediate neuronal inhibition. These variants lead to receptor functional deficits that manifest as neurological syndromes in young affected individuals.
We aim to characterise the functional deficists in these receptors and explore personalised treatment options that are tailored to each receptor variant.
-
Glutamate (NMDA) receptors in develpmental delay
Genetic variants to glutamate receptors have been discovered by our clinical geneticists. We aim the understand how these variants lead to developmental delay and co-morbid disorders in affected individuals and explore pharmacotherapies that correct the functional deficits in these important receptors.
-
Tuning the activating stimulus of voltage-gated sodium channels
This project will use natural and modified peptides that are derived from venoms of different species, such as spiders and ants to probe and manipulate the functional properties of voltage-gated ion channels, which are critically important to the function of the nervous system.
You will learn patch-clamp electrophysiology (whole-cell and single channels) and how to isolate, synthesise and determine the structure of venom peptides and their mechanisms of action at ion channels.
Supervision history
Current supervision
-
Doctor Philosophy
Probing ion channel function using venom peptides
Principal Advisor
Other advisors: Professor Irina Vetter
-
Doctor Philosophy
Investigating ion channel function and pathology using toxins as tools
Associate Advisor
Other advisors: Dr Jennifer Deuis, Professor Irina Vetter
Completed supervision
-
2019
Doctor Philosophy
Glutamate-gated chloride channel receptors and mechanisms of drug resistance in pathogenic species
Joint Principal Advisor
-
2022
Master Philosophy
Investigating the role of the novel GABAA receptor variant, ß2(L51M), in the pathophysiology of epilepsy
Associate Advisor
Other advisors: Professor Irina Vetter
-
2019
Master Philosophy
Characterization of novel synthetic analgesics selectively targeting Alpha3 Glycine receptors
Associate Advisor
-
2019
Doctor Philosophy
Pharmacological and physiological investigation of GABAA and NMDA receptors containing epilepsy mutations
Associate Advisor
-
2017
Doctor Philosophy
Physiological properties of glycinergic synapses with defined subunit compositions
Associate Advisor
Other advisors: Professor Pankaj Sah
-
2016
Doctor Philosophy
Discovering novel alpha5-containing GABA-A receptor selective drugs for schizophrenia, stroke and cognitive impairments
Associate Advisor
-
2015
Doctor Philosophy
Identification and characterization of new synthetic drugs selectively targeting alpha3 glycine receptors as therapeutic leads for pain treatment
Associate Advisor
-
2014
Doctor Philosophy
Effects of new Hyperekplexia Mutations on Human Glycine Receptor Structure and Function
Associate Advisor
-
2013
Doctor Philosophy
Voltage-Clamp Fluorometry of Glycine Receptors: Relevance to Pain and Startle Disease
Associate Advisor
Media
Enquiries
For media enquiries about Dr Angelo Keramidas's areas of expertise, story ideas and help finding experts, contact our Media team: